Graphjet (ENCP) posts heavy losses, going-concern and Nasdaq compliance risk

Graphjet Technology (NASDAQ: ENCP) - Snapshot of what's happening inside the company

Graphjet is a pre-revenue carbon/graphene-technology manufacturer that completed a SPAC-style reverse recapitalization in March 2024. During the reporting period ended March 31, 2025 the company continued to invest in plant & equipment, recorded losses, and faced material liquidity and governance issues that created a formal going-concern disclosure and a Nasdaq listing compliance process. Management has taken steps (debt-settlement agreements, share issuances, equipment purchases) but material risks remain.

Key facts & statistics (from the 10‑Q, as reported)

- Revenues: $- (no product revenue for the quarter/period reported).
- Three‑month net loss (ended Mar 31, 2025): $(577,023).
- Six‑month net loss (ended Mar 31, 2025): $(1,266,178).
- General & administrative expense: $552,947 (3 months) and $1,205,005 (6 months).
- Cash (Mar 31, 2025): $227,828 (down from $348,655 at Sept 30, 2024).
- Total assets: $1,977,239; Total liabilities: $20,311,678; Shareholders' deficit: $(18,334,439).
- Negative working capital: $19,803,945 (as disclosed).
- Provision for bonus on the balance sheet: $13,800,000 (unchanged).
- Inventories (work‑in‑progress): $137,670 (Mar 31, 2025) vs $73,922 (Sept 30, 2024).
- Property & equipment, net: $1,426,900 (Mar 31, 2025).
- Loans from third parties: $570,991; Loans from shareholders: $447,896; Payables to shareholders: $2,008,793.
- Cash used in operating activities (six months): $(1,148,794).
- Net change in cash (six months): $(120,827).
- Subsequent material events: Nasdaq compliance hearing, equipment purchase ~$299,000 (June 26, 2025) to expand capacity (~7x), and multiple debt settlement/subscription agreements (Apr-Aug 2025).
- Governance / accounting: restatement of prior periods, disclosed material weaknesses in internal control.

What's working (positives)

- Costs materially lower year‑over‑year vs the restated prior period because a one‑time $13.8M bonus provision recorded in prior period was not repeated; run‑rate G&A is small (≈$0.5-1.2M).
- Management obtained financing events in 2024-2025 (PIPE $2.5M, Nov 1, 2024 fundraising ~ $1.0M net, plus additional shareholder support and short-term related‑party loans) that helped bridge near-term cash needs.
- Company moved to production, increased inventory WIP and purchased higher‑capacity equipment (~$299k) to raise output and product quality (management claims ~7x capacity improvement).
- Management negotiated debt settlement agreements with key shareholders/directors to restructure obligations.

Main negatives (income statement & financial health)

- No product revenue for the reporting period (Revenues: $-). The company only began selling side products in June 2025 (after the period end).
- Recurring net losses: $(577k) for the quarter and $(1.27M) for six months - cash burn remains significant relative to cash on hand ($227k).
- Balance sheet is heavily levered and imbalanced: liabilities (~$20.3M) vs assets (~$2.0M) yielding a shareholders' deficit of $(18.33M).
- Material off‑balance governance/accounting issues: prior period restatements, material weaknesses in internal control, and continuing Nasdaq compliance risk (conditional stay and deadlines imposed by Panel).
- Large non‑operational liabilities skew results: $13.8M provision for bonus remains on the balance sheet and payables to shareholders total ~$2.0M - these are not cash‑generating assets.
- Negative working capital (~$19.8M) and modest cash balance create substantial going‑concern risk unless financing or revenue ramps quickly.

Bottom line / concise takeaways
- Graphjet (NASDAQ: ENCP) is a technology/production company with IP and early production capability but no meaningful reported product revenue in the period; it posted modest losses in 2025 while burning cash.
- The balance sheet shows a large deficit and concentrated related‑party liabilities; management has renegotiated debts and invested in equipment to scale production, but liquidity remains tight (cash $227,828) and the company disclosed substantial doubt about continuing as a going concern.
- Corporate governance and reporting problems (restatements, internal control weaknesses) plus Nasdaq compliance deadlines are immediate execution risks; success depends on meeting Nasdaq filing/bid‑price conditions, completing fundraising or rapid commercial traction from product sales.

If you want, I can:

- produce a 1‑page investment risk/prospective scorecard, or

- pull the most recent SEC filing updates or market data for the ticker page (ENCP).